GlassScriptPhysician profile
Joseph R Mckinlay
NPI 1609844588
$2,021.16
in general payments reported to CMS, 2019-2025
9 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.06 · 2020: $84.99 · 2021: $280 · 2022: $215 · 2023: $345 · 2024: $445 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.40 |
| Education | $170.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $548.12 | 2020-2025 | Dupixent |
| Genzyme Corporation | $496.98 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $409.82 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $278.96 | 2020-2025 | Ilumya |
| Leo Pharma INC. | $131.20 | 2024-2025 | Adbry |
| Amgen INC. | $91.17 | 2019-2021 | |
| Incyte Corporation | $43.67 | 2023-2025 | Opzelura |
| Pfizer INC. | $12.95 | 2023 | |
| Organon LLC | $8.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mckinlay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.